China · Delayed Price · Currency is CNY Tibet Weixinkang Medicine Statistics
Total Valuation
SHA:603676 has a market cap or net worth of CNY 3.50 billion. The enterprise value is 2.50 billion.
| Market Cap | 3.50B |
| Enterprise Value | 2.50B |
Important Dates
The last earnings date was Friday, October 30, 2026.
| Earnings Date | Oct 30, 2026 |
| Ex-Dividend Date | Jun 29, 2026 |
Share Statistics
SHA:603676 has 432.33 million shares outstanding. The number of shares has increased by 0.81% in one year.
| Current Share Class | 432.33M |
| Shares Outstanding | 432.33M |
| Shares Change (YoY) | +0.81% |
| Shares Change (QoQ) | -3.08% |
| Owned by Insiders (%) | 22.96% |
| Owned by Institutions (%) | 2.47% |
| Float | 94.10M |
Valuation Ratios
The trailing PE ratio is 18.39.
| PE Ratio | 18.39 |
| Forward PE | n/a |
| PS Ratio | 3.21 |
| PB Ratio | 2.22 |
| P/TBV Ratio | 2.25 |
| P/FCF Ratio | 26.94 |
| P/OCF Ratio | 15.90 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 12.89, with an EV/FCF ratio of 19.22.
| EV / Earnings | 13.13 |
| EV / Sales | 2.29 |
| EV / EBITDA | 12.89 |
| EV / EBIT | 17.55 |
| EV / FCF | 19.22 |
Financial Position
The company has a current ratio of 3.96, with a Debt / Equity ratio of 0.01.
| Current Ratio | 3.96 |
| Quick Ratio | 3.46 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.05 |
| Debt / FCF | 0.07 |
| Interest Coverage | 2,449.33 |
Financial Efficiency
Return on equity (ROE) is 12.27% and return on invested capital (ROIC) is 23.05%.
| Return on Equity (ROE) | 12.27% |
| Return on Assets (ROA) | 4.60% |
| Return on Invested Capital (ROIC) | 23.05% |
| Return on Capital Employed (ROCE) | 8.83% |
| Weighted Average Cost of Capital (WACC) | 4.11% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | 763 |
| Asset Turnover | 0.56 |
| Inventory Turnover | 8.49 |
Taxes
In the past 12 months, SHA:603676 has paid 31.94 million in taxes.
| Income Tax | 31.94M |
| Effective Tax Rate | 14.38% |
Stock Price Statistics
The stock price has decreased by -30.17% in the last 52 weeks. The beta is -0.02, so SHA:603676's price volatility has been lower than the market average.
| Beta (5Y) | -0.02 |
| 52-Week Price Change | -30.17% |
| 50-Day Moving Average | 8.76 |
| 200-Day Moving Average | 9.63 |
| Relative Strength Index (RSI) | 33.91 |
| Average Volume (20 Days) | 1,897,586 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHA:603676 had revenue of CNY 1.09 billion and earned 190.23 million in profits. Earnings per share was 0.44.
| Revenue | 1.09B |
| Gross Profit | 637.71M |
| Operating Income | 142.37M |
| Pretax Income | 222.17M |
| Net Income | 190.23M |
| EBITDA | 183.21M |
| EBIT | 142.37M |
| Earnings Per Share (EPS) | 0.44 |
Balance Sheet
The company has 1.01 billion in cash and 9.45 million in debt, with a net cash position of 1.00 billion or 2.32 per share.
| Cash & Cash Equivalents | 1.01B |
| Total Debt | 9.45M |
| Net Cash | 1.00B |
| Net Cash Per Share | 2.32 |
| Equity (Book Value) | 1.57B |
| Book Value Per Share | 3.70 |
| Working Capital | 1.02B |
Cash Flow
In the last 12 months, operating cash flow was 220.20 million and capital expenditures -90.21 million, giving a free cash flow of 130.00 million.
| Operating Cash Flow | 220.20M |
| Capital Expenditures | -90.21M |
| Depreciation & Amortization | 40.84M |
| Net Borrowing | -4.02M |
| Free Cash Flow | 130.00M |
| FCF Per Share | 0.30 |
Margins
Gross margin is 58.51%, with operating and profit margins of 13.06% and 17.45%.
| Gross Margin | 58.51% |
| Operating Margin | 13.06% |
| Pretax Margin | 20.38% |
| Profit Margin | 17.45% |
| EBITDA Margin | 16.81% |
| EBIT Margin | 13.06% |
| FCF Margin | 11.93% |
Dividends & Yields
This stock pays an annual dividend of 0.33, which amounts to a dividend yield of 4.04%.
| Dividend Per Share | 0.33 |
| Dividend Yield | 4.04% |
| Dividend Growth (YoY) | -4.39% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 77.14% |
| FCF Payout Ratio | 108.75% |
| Buyback Yield | -0.81% |
| Shareholder Yield | 3.23% |
| Earnings Yield | 5.44% |
| FCF Yield | 3.71% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |